GO
Loading...

Celgene Corp

More

  • Final Glance: Biotechnology companies Wednesday, 26 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose $2.48 or 1.5 percent, to $164.72. Biogen Idec fell$. 48 or. 2 percent, to $304.92. Celgene Corp. rose $1.54 or 1.4 percent, to $112.61.

  • Midday Glance: Biotechnology companies Wednesday, 26 Nov 2014 | 2:02 PM ET

    Amgen Inc. rose $1.39 or. 9 percent, to $163.63. Biogen Idec fell $1.87 or. 6 percent, to $303.53. Celgene Corp. rose $1.31 or 1.2 percent, to $112.38.

  • Teva Pharma names Peterburg new chairman Wednesday, 26 Nov 2014 | 1:39 PM ET

    Nov 26- The board of Teva Pharmaceutical Industries Ltd elected Yitzhak Peterburg as its chairman, succeeding Phillip Frost, who is due to step down at the end of the year. The company also appointed Sol Barer, the former chief executive of Celgene Corp, as a director. Teva stock was up 0.8 percent at $57.02 on the New York Stock Exchange.

  • Early Glance: Biotechnology companies Wednesday, 26 Nov 2014 | 10:24 AM ET

    Amgen Inc. rose$. 92 or. 6 percent, to $163.16. Biogen Idec fell $1.90 or. 6 percent, to $303.50. Celgene Corp. rose$. 73 or. 7 percent, to $111.80.

  • Final Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 6:57 PM ET

    Amgen Inc. fell $1.94 or 1.2 percent, to $162.24. Biogen Idec fell $1.34 or. 4 percent, to $305.40. Celgene Corp. rose$. 09 or. 1 percent, to $111.07.

  • Midday Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 1:17 PM ET

    Amgen Inc. fell $1.86 or 1.1 percent, to $162.32. Biogen Idec fell $2.53 or. 8 percent, to $304.21. Celgene Corp. fell$. 15 or. 1 percent, to $110.83.

  • Early Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 10:22 AM ET

    Amgen Inc. fell $2.11 or 1.3 percent, to $162.07. Biogen Idec fell$. 12 or percent, to $306.62. Celgene Corp. fell$. 35 or. 3 percent, to $110.63.

  • Final Glance: Biotechnology companies Monday, 24 Nov 2014 | 6:08 PM ET

    Amgen Inc. rose $1.37 or. 8 percent, to $164.18. Biogen Idec rose $3.19 or 1.1 percent, to $306.74. Celgene Corp. rose $2.78 or 2.6 percent, to $110.98.

  • Early Glance: Biotechnology companies Monday, 24 Nov 2014 | 10:26 AM ET

    Amgen Inc. rose $2.73 or 1.7 percent, to $165.54. Biogen Idec rose $3.62 or 1.2 percent, to $307.17. Celgene Corp. rose $2.12 or 2.0 percent, to $110.32.

  • Final Glance: Biotechnology companies Friday, 21 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 13 or. 1 percent, to $162.81. Biogen Idec rose $4.45 or 1.5 percent, to $303.55. Celgene Corp. rose$. 85 or. 8 percent, to $108.20.

  • Early Glance: Biotechnology companies Friday, 21 Nov 2014 | 10:17 AM ET

    Amgen Inc. fell$. 16 or. 1 percent, to $162.52. Biogen Idec rose $3.56 or 1.2 percent, to $302.66. Celgene Corp. rose $1.30 or 1.2 percent, to $108.65.

  • Final Glance: Biotechnology companies Thursday, 20 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 04 or percent, to $162.68. Biogen Idec fell $4.51 or 1.5 percent, to $299.10. Celgene Corp. rose$. 37 or. 3 percent, to $107.35.

  • Midday Glance: Biotechnology companies Thursday, 20 Nov 2014 | 2:49 PM ET

    Amgen Inc. rose $1.79 or 1.1 percent, to $164.43. Biogen Idec fell $1.84 or. 6 percent, to $301.78. Celgene Corp. rose$. 60 or. 6 percent, to $107.58.

  • Early Glance: Biotechnology companies Thursday, 20 Nov 2014 | 10:29 AM ET

    Amgen Inc. rose$. 44 or. 3 percent, to $163.08. Biogen Idec fell$. 30 or. 1 percent, to $303.31. Celgene Corp. fell$. 16 or. 2 percent, to $106.82.

  • Final Glance: Biotechnology companies Wednesday, 19 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 40 or. 2 percent, to $162.64. Biogen Idec fell $1.95 or. 6 percent, to $303.61. Celgene Corp. rose$. 20 or. 2 percent, to $106.98.

  • Midday Glance: Biotechnology companies Wednesday, 19 Nov 2014 | 1:31 PM ET

    Amgen Inc. rose$. 39 or. 2 percent, to $162.63. Biogen Idec fell $1.63 or. 5 percent, to $303.93. Celgene Corp. rose$. 79 or. 7 percent, to $107.57.

  • Early Glance: Biotechnology companies Wednesday, 19 Nov 2014 | 12:00 PM ET

    Amgen Inc. fell $1.18 or. 7 percent, to $161.06. Biogen Idec fell $1.69 or. 6 percent, to $303.87. Celgene Corp. fell$. 80 or. 7 percent, to $105.98.

  • Final Glance: Biotechnology companies Tuesday, 18 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose $3.10 or 1.9 percent, to $162.24. Biogen Idec rose $3.14 or 1.0 percent, to $305.56. Celgene Corp. rose $2.42 or 2.3 percent, to $106.78.

  • Actavis Plc, Gilead Sciences, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.6 percent, while shares of Actavis were up 8.3 percent, Gilead's rose 3.3 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.

  • US STOCKS-S&P 500 hits record, healthcare leads gains Tuesday, 18 Nov 2014 | 1:45 PM ET

    Actavis Plc, Gilead, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.4 percent, while shares of Actavis were up 7.7 percent, Gilead's rose 2.9 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.